In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter. Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss benefits. Thirteen states cover GLP-1 drugs through their Medicaid programs, and others are considering following suit. (Mario Tama/Getty Images) Over […]
The post is from Mad Mad News